3 Reasons to Buy This Blue-Chip Stock
2022 has been characterized by a paradigm shift from growth stocks to dividend stocks.
Mindfully Curated
2022 has been characterized by a paradigm shift from growth stocks to dividend stocks.
Investors expect its lofty valuation to keep coming down despite strong business fundamentals.
If you can handle a moderate level of risk in your investments, you could be looking at a seven-digit portfolio total in 30 years.
Its high dividend yield is only one part of the story.
The energy company has agreed to be acquired. The stock did exactly what you would expect. Here are the quick details.
Despite what the stock’s recent performance might indicate, the streaming platform keeps growing.
FDA briefing documents in advance of next week’s advisory committee meeting highlighted potential safety issues with Novavax’s COVID-19 vaccine.
This pet health insurer has been beaten down largely by the market downturn.
Folks are ready for a summer of fun, and Airbnb is prepared to capitalize on the travel demand.
Capri Holdings is hitting all the right notes.
The craft store reported earnings and the numbers weren’t very good. The outlook was, perhaps, even worse.
The cloud software giant is still growing at an impressive rate.
Regardless of who wins the championship series, the event will likely generate lots of interest from sports fans.
As restrictions in China begin to ease, these three companies are well-positioned to capitalize in both the near and long term.
Wall Street analysts expect Block and Bill.com to bounce back. Will they?
The company keeps burning through cash as its business grows.
It was a great quarter, but there are some nuances to understand about P&G’s ability to raise prices.
The company just announced an acquisition that makes its growth strategy much clearer.
These two healthcare companies have been around a long time.
A team of public health modelers and substance use experts has developed a dynamic model based on national data from 1999 to 2020 that tracks the evolution of the opioid crisis for public policy analysis and development.